Elsa Arbajian

Medicine & Life Sciences

1. Gene Fusion 100%
2. Fibrosarcoma 62%
3. Sarcoma 55%
4. Neoplasms 46%
5. calcifying aponeurotic fibroma 27%
6. RNA Sequence Analysis 26%
7. sis Genes 23%
8. Proteogenomics 23%
9. Chromosomes, Human, Pair 22 22%
10. Genes 21%
11. Myoepithelioma 21%
12. High-Throughput Nucleotide Sequencing 21%
13. Osteoblastoma 21%
14. Receptor Protein-Tyrosine Kinases 21%
15. Dermatofibrosarcoma 20%
16. Angiofibroma 20%
17. Somatomedin Receptors 18%
18. Bone and Bones 18%
19. Chromosome Deletion 18%
20. Liposarcoma 17%
21. Immune Evasion 17%
22. Mutation 16%
23. Wnt Signaling Pathway 15%
24. Lung Neoplasms 15%
25. Hemangioma 15%
26. Adenocarcinoma of Lung 14%
27. Epidermal Growth Factor 13%
28. Angiolipoma 13%
29. Fluorescence In Situ Hybridization 13%
30. Molecular Biology 12%
31. Methylation 12%
32. Non-Small Cell Lung Carcinoma 12%
33. Phosphotransferases 12%
34. Chromatin 12%
35. Whole Exome Sequencing 12%
36. Soft Tissue Neoplasms 12%
37. Platelet-Derived Growth Factor beta Receptor 12%
38. Proto-Oncogene Proteins c-sis 12%
39. Gene Expression 11%
40. Chromosomes 11%
41. Atlases 9%
42. Single Nucleotide Polymorphism 9%
43. Chromosome Banding 9%
44. Polymerase Chain Reaction 8%
45. RNA-Seq 8%
46. Genome 8%
47. Blood Vessels 8%
48. Neoplasm Metastasis 8%
49. Recurrence 7%
50. Survival 7%